US Material Events SEC 8-K Filings — October 16, 2026

16-10-2026

RYTHM, Inc. (Nasdaq: RYM) amended its Trademark and Recipe License Agreement with GTI Core, LLC (an indirect subsidiary of Green Thumb Industries) on October 13, 2026, adding the Señorita brand to the licensed IP. The Señorita rights to sell outside state-regulated dispensary channels are reserved for RYTHM if and when federal law changes permit it, and the Annual Fee for 2026 is set at $64,250,000 (monthly installments of $5,354,166.67), with a $250,000 per-year increase in base licensing fees attributed to the added rights. The filing does not report any measure of financial performance, so no period-over-period comparison is available.

• · Green Thumb is an indirect owner of approximately 32% of RYTHM's common stock and may increase beneficial ownership to approximately 90%
• · Chairman and CEO of Green Thumb (Benjamin Kovler) also serves as RYTHM's Chairman and Interim CEO, creating related-party governance overlap
• · Exclusive rights for Señorita outside state-regulated dispensary channels are contingent on future legal permissibility and Nasdaq listing standards
• · The Amendment is 'Amendment No. 2' to the August 27, 2025 license agreement; Amendment No. 1 was executed March 31, 2026

16-10-2026

Ironwood Pharmaceuticals' Board appointed Chief Commercial Officer Tammi Gaskins as Chief Executive Officer and a Board member, effective January 1, 2027, when Tom McCourt retires from the CEO role after 17 years at the company; McCourt will remain on the Board. The transition follows a turnaround year in which LINZESS was returned to blockbuster status and growth, though the release provides no specific financial figures for the period.

• · Gaskins led commercial development efforts for apraglutide, a once-weekly GLP-2 analog in Phase 3 for adults with short bowel syndrome with intestinal failure (SBS-IF)
• · LINZESS is described as the #1 prescribed brand in the U.S. for IBS-C or CIC, based on IQVIA data
• · McCourt led the acquisition of VectivBio, which brought apraglutide into Ironwood's late-stage pipeline
• · McCourt previously held commercial and drug development roles at Merck, Astra Merck, AstraZeneca, Novartis and Amgen
• · The company states it strengthened its balance sheet during 2026, though no figures are disclosed in this release

16-10-2026

StepStone Private Credit Fund LLC filed Exhibit 10.1, Amendment No. 5 to its Loan and Security Agreement for the StepStone SPV Facility III LLC borrowing facility, dated October 15, 2026, among Wells Fargo (administrative agent and swingline lender), UMB Bank (collateral agent), and several lenders. The amendment is conformed in the appendix to a facility size of $1,000,000,000, up from $750,000,000 in the prior conformed version, and includes a revised Applicable Spread of 1.95% per annum (down from 2.15%) and extended the maturity or terms as reflected in the redlined text. Parties represented no Default or Event of Default existed at signing, and the amendment is effective subject to customary conditions including legal opinion and fee payment.

• · Representations confirm no Default, Event of Default, or Change of Control for the Borrower, Collateral Manager, or Equityholder as of the Amendment Date.
• · Effectiveness is conditioned on a legal opinion from Akin Gump, a Delaware good standing certificate, manager resolutions, and payment of Administrative Agent fees.
• · Governing law is New York, and the amendment forms part of the LSA for all purposes.
• · The Applicable Percentage and Assigned Value terms are unchanged in the excerpt provided and some redlined provisions are not fully legible in the filing text.

16-10-2026

Scotts Miracle-Gro disclosed that Christopher J. Hagedorn, its former Executive Vice President & Chief Strategy Officer, departed on September 30, 2026. Under a Separation Agreement dated October 13, 2026, he receives 24 months of salary, 12 months of outplacement support, 24 months of COBRA benefits offset, and a bonus amount equal to 2.0 times his target bonus payable in two installments. Unvested equity awards are largely forfeited, while 57,033 options vested in full and remain exercisable for 180 days, and 16,239 performance units remain eligible to vest in February 2027 subject to performance criteria.

• · Hagedorn is eligible for a fiscal 2026 incentive payout under the Executive Incentive Plan, payable November 2026, based on target bonus through the Termination Date multiplied by funded plan results and a discretionary personal performance factor
• · Separation payments are conditioned on Hagedorn not revoking acceptance of the agreement and, for bonus installments, on continued compliance with post-employment obligations
• · Restrictive covenants include noncompetition, confidentiality, cooperation and nonsolicitation, reinforced by a prior agreement dated August 30, 2024 that remains in effect
• · Hagedorn retains vested benefits under the company's retirement and retiree medical plans

16-10-2026

Global Partners LP and its subsidiaries entered into the Twelfth Amendment to the Third Amended and Restated Credit Agreement dated October 16, 2026, which restructures the lender group by having The Toronto-Dominion Bank, KeyBank, National Association and ING Capital LLC exit while TD Bank, N.A., PNC Bank, U.S. Bank and Valley National Bank join as New Lenders. The amendment also joins Hampton Development LLC as a new guarantor and Loan Party, and increases the Loan Parties' annual financial loss limit under their risk policy. The filing does not disclose dollar amounts for facility size or commitments in the excerpt provided.

• · Hampton (Global Hampton 95 Development LLC) joins the Guaranty as a Guarantor and becomes a Loan Party, jointly and severally liable for all Obligations, and grants a security interest in substantially all personal property collateral.
• · The Loan Parties' annual financial loss limit under their risk policy was increased from the prior policy; the amended policy is referenced in Section 7.13 of the Credit Agreement.
• · Bank of America, N.A. serves as Administrative Agent, Swing Line Lender, L/C Issuer and Alternative Currency Fronting Lender; JPMorgan Chase Bank, N.A. serves as an L/C Issuer.
• · The Existing Credit Agreement is the Third Amended and Restated Credit Agreement dated April 25, 2017; the Existing Guaranty and Existing Security Agreement are dated the same day.
• · Assignments are made at par and without recourse; Exiting Lenders are reduced to zero WC, WC Interim and Revolver Commitments.
• · Section 5 (Conditions to Effectiveness) was not included in the provided excerpt, so the Amendment Effective Date and conditions are not confirmed here.

16-10-2026

Quantum Cyber N.V. (formerly MAINZ BIOMED N.V., ticker QUCY on Nasdaq Capital Market) disclosed in an 8-K dated October 16, 2026 that its board appointed Major General (Retired) Alberto C. Rosende as an independent director effective October 12, 2026, placing him on the Audit, Compensation, and Nomination Committees. The same day, director and Quantum Drones President Peter M. O'Rourke resigned from the board and his role, and his employment agreement (effective July 1, 2026) was terminated; the company states the resignation was not due to any disagreement with the company. The filing contains no financial figures.

• · Maj. Gen. (Ret.) Rosende serves as President and CEO of M2i Global Inc. since September 2024 and previously was its VP of Business Operations and Integration (March 2023 to August 2024)
• · Rosende was Commanding General of the 63rd Readiness Division covering seven southwestern states, and is a combat veteran of Afghanistan and Iraq
• · Board found Rosende independent under Nasdaq listing standards and financially literate for audit committee purposes
• · Rosende's director compensation follows the standard non-employee director program described in the June 1, 2026 DEF 14A proxy
• · Filing states no arrangements or understandings with any other person regarding Rosende's appointment and no related-party transaction interest under Item 404(a)
• · Filing is an emerging growth company under the 2026 cover page and the company name appears to have changed from MAINZ BIOMED N.V. (name change dated November 12, 2021 per EDGAR header)

16-10-2026

Terra Innovatum Global N.V. (NKLR) dismissed KPMG Accountants N.V. as its independent registered public accounting firm, effective October 12, 2026, and has approved MaloneBailey, LLP as its successor for fiscal 2026, subject to client acceptance procedures. The Audit Committee states the change is not due to any disagreement with KPMG, and KPMG's FY2025 audit report carried no adverse opinion, disclaimer, or qualification. However, the filing discloses that material weaknesses in internal control over financial reporting, first disclosed in the FY2025 Form 10-K and the Q2 2026 Form 10-Q, have not been remediated.

• · KPMG served only for FY2025, and MaloneBailey previously served as auditor from April 29, 2025 to January 15, 2026
• · Material weaknesses were reported in the FY2025 Form 10-K (filed June 16, 2026) and the Q2 2026 Form 10-Q (filed August 14, 2026) and remain unremediated
• · KPMG has been authorized to respond fully to MaloneBailey's inquiries regarding the material weaknesses
• · KPMG's letter dated October 16, 2026 is filed as Exhibit 16.1
• · The company is an emerging growth company (EGC)

16-10-2026

Alector, Inc. (ALEC) announced the pricing of an underwritten public offering of 36,600,000 shares of common stock at $2.05 per share, a premium of approximately 7.3% to the October 15, 2026 closing price, for expected gross proceeds of $75,030,000 before underwriting discounts, commissions, and offering expenses. The offering is expected to close on or about October 19, 2026, and is being made under an effective shelf registration statement with Morgan Stanley & Co. LLC and BTIG, LLC as joint lead book-running managers. Proceeds are earmarked for general corporate purposes, including research, development and manufacturing, working capital, and potential acquisitions.

• · Offering is expected to close on or about October 19, 2026, subject to customary closing conditions
• · Offering is made under a previously filed and SEC-effective shelf registration statement
• · Participants include both new and existing investors, including TCGX, BVF Partners, ADAR1 Capital Management and Deep Track Capital
• · Company focuses on neurodegenerative disease candidates including Alzheimer's and Parkinson's, with no revenue or earnings data disclosed in this release
• · Release contains no financial results, cash balance, or runway disclosure, so the capital raise cannot be assessed against current liquidity

16-10-2026

CID HoldCo, Inc. (Nasdaq: DAIC/DAICW) entered into Debt Settlement and Share Issuance Agreements on October 9, 2026 with CEO Edmund S. Nabrotzky, CFO/COO Charles Maddox, and CTO Vijayan Nambiar, under which the executives waived approximately $368,107.25 in principal and accrued interest on their Executive Notes in exchange for 55,613 common shares at a deemed $6.00 per share and a cash payment of about $37,075 (roughly 10% of the debt). Separately, as of October 15, 2026, the company committed to issue 752,889 shares to other creditors on substantially similar terms. The arrangement is a related-person transaction approved by the board and Audit Committee, and the company states it is not a compensatory arrangement.

• · Executive Notes accrued 7.5% interest, with quarterly installments due July 1 and October 1, 2026 and a final payment due December 31, 2026.
• · Settlement Shares must be registered for resale by November 30, 2026, and are locked up through April 15, 2027.
• · If the Cash Portion is not paid by December 31, 2026, the waiver terminates, but executives keep the Settlement Shares and may pursue the full debt.
• · The company reports no early termination penalties and receives no cash proceeds from the share issuances.
• · Shares issued under Section 4(a)(2) and/or Rule 506(b) private placement exemptions.
• · The filing states the parties intend to continue their business relationship, with the company seeking to keep executives working with it.
• · The 8-K discloses the company's Nasdaq-listed warrants (DAICW) with a $287.50 exercise price, far above the $6.00 deemed issuance price, and the filing does not explain this gap.

16-10-2026

Conduent Incorporated and two subsidiaries entered into a Class Action Settlement Agreement and Release to resolve the consolidated class action In re: Conduent Business Services Data Breach Litigation, pending in the U.S. District Court for the District of New Jersey, arising from the company's January 2025 cybersecurity incident. The company will fund $80 million into a non-reversionary settlement fund, which is its total monetary obligation and is inclusive of class member recovery, credit and medical data monitoring, plaintiffs' counsel fees, and administration costs; the settlement remains subject to Court approval and the company denies fault, while management states it maintains cyber insurance and does not expect a material impact on financial position, results of operations, or cash flows.

• · The settlement releases the company, its affected clients, and such clients' affected customers from claims arising out of or relating to the cyber incident, upon final approval
• · The company's monetary exposure is capped at $80M under the agreement, and the company explicitly states it is not an admission of fault or liability
• · Settlement is qualified by Exhibit 10.1 (Class Action Settlement Agreement and Release dated October 16, 2026)

16-10-2026

Cipher Digital Inc. (f/k/a Cipher Mining Inc., ticker CIFRW) issued notices on October 16, 2026 that the Default Settlement Method for its 1.75% Convertible Senior Notes due 2030 and its 0.00% Convertible Senior Notes due 2031 is changed to Physical Settlement. Under this change, Notes surrendered for conversion on or after the notice date will be settled physically unless the Company specifies otherwise under Section 5.03(A)(i) of the applicable indenture. The filing does not disclose financial results, deal values, or dollar amounts.

• · CUSIP/ISIN for 2030 Notes: 17253J AA4 / US17253JAA43; for 2031 Notes: 17253J AB2 / US17253JAB26
• · First Supplemental Indenture for the 2030 Notes is dated May 22, 2025; the base Indenture for the 2031 Notes is dated September 30, 2025
• · Change was made under clause (x) of the 'Default Settlement Method' definition in Section 1.01 of each indenture
• · The 2031 Notes are titled '0.00% Convertible Senior Notes due 2030' in the body text but '2031' in the heading, a naming inconsistency in the filing
• · Filing also lists Items 1.01, 2.03, 3.02, and 9.01, which may reference related agreements, obligations, or unregistered share issuances not included in this excerpt

16-10-2026

VivoSim Labs, Inc. (Nasdaq: VIVS) disclosed that its wholly-owned subsidiary Organovo, Inc. entered into a Second Amendment to its Amended and Restated Lease with San Diego Inspire 2, LLC on October 13, 2026, covering its principal executive offices at 11555 Sorrento Valley Road, San Diego. The amendment requires the company to vacate Suite 202 by February 28, 2027, extends the term for Suite 100 through April 30, 2028, and sets monthly base rent at $43,072.85, with a rent abatement of $21,536.43 per month from March 1, 2027 through June 30, 2027 (aggregate $86,145.70). The filing is a routine lease modification that reduces footprint and provides limited near-term rent relief, with no other financial results disclosed.

• · Lease covers principal executive offices at 11555 Sorrento Valley Road, Suite 100, San Diego, CA 92121
• · Original lease dated November 23, 2020; First Amendment dated November 17, 2021
• · Suite 202 must be vacated and surrendered on or before February 28, 2027, reducing leased premises
• · Suite 100 lease term extended from March 1, 2027 through April 30, 2028
• · Lease includes other unspecified modifications to terms and provisions
• · Full amendment filed as Exhibit 10.1 with iXBRL cover page as Exhibit 104

16-10-2026

Arrive AI Inc. (ARAI) disclosed that its independent auditor, Stephano Slack LLC, resigned effective October 13, 2026, and that the Audit Committee engaged M&K CPAS, PLLC as its new independent registered public accounting firm the same day. The prior auditor's reports for fiscal 2025 carried a going-concern explanatory paragraph, and the company disclosed an unremediated material weakness in internal control over financial reporting tied to embedded derivatives and debt discount accounting, which led to restated 10-Q/A filings in April 2026.

• · Stephano Slack's audit reports for fiscal 2025 included a substantial doubt going-concern paragraph, signaling financial viability concerns
• · Reportable event under Item 304(a)(1)(v): material weakness related to embedded derivatives in hybrid instruments and effective interest method for discounted host debt, not fully remediated as of June 30, 2026
• · M&K CPAS was engaged to review Q3 2026 interim statements and audit FY2026, and the company states no prior consultations with M&K on accounting matters or reportable events
• · Stephano Slack's response letter (Exhibit 16.1) dated October 16, 2026 is filed with the SEC and will state whether it agrees with the company's disclosures

16-10-2026

Northann Corp. (NCL) disclosed in an 8-K that its Board of Directors elected Mr. Dat Nguyen as a director on October 12, 2026, to fill the vacancy created by the resignation of Mr. Lin Li. Mr. Nguyen was determined to be independent under NYSE American listing rules and financially literate, and will join the Audit, Nomination and Compensation Committees; the board returns to a full five members, including three independent directors.

• · Mr. Nguyen will serve on the Audit, Nomination and Compensation Committees
• · Mr. Nguyen previously led EY Indochina's Technology Advisory Practice (January to October 2017) and served as Country Director of Accenture Vietnam (August 2012 to September 2015)
• · Mr. Nguyen has been an angel investor and advisor to startups in AI, blockchain, and quantum-safe cybersecurity since 2018
• · Mr. Nguyen holds a B.A.Sc. in Engineering and a B.Sc. in Biology from the University of Ottawa and completed executive education at Harvard Kennedy School and MIT Sloan
• · No familial or other relationships with directors or management, and no Item 404(a) related-party transactions disclosed
• · Filing is signed by Bradley Lalonde, who serves as both Chairman and CEO, and is dated October 15, 2026

16-10-2026

International Seaways (INSW) agreed to acquire Bruton Limited (valued at about $370 million) in a two-step transaction: an immediate First-Step Exchange for 50.5% of Bruton shares at 0.0519 INSW shares per Bruton share, followed by a cash-and-stock merger for the remainder, with about 3.12 million INSW shares issued (about 96% of consideration). The company also reported preliminary Q3 2026 results showing shipping revenues of about $480-$490 million and net income of about $340-$350 million (including a roughly $50 million gain on a Suezmax sale), while blended spot earnings fell to about $68,000 per day from $79,000 in Q2 2026, though still well above $29,000 per day in Q3 2025.

• · First-Step Exchange expected to settle on or about October 20, 2026
• · Bruton special shareholder meeting on or about October 30, 2026; shareholders party to the First-Step Exchange agreed to vote in favor
• · Merger expected to close promptly after the Bruton special meeting, subject to customary conditions
• · Q3 2026 preliminary results to be finalized in the full earnings release on November 5, 2026
• · Preliminary Q3 2026 results are subject to completion of financial closing procedures and may change
• · Transaction structured under Rule 802 exemption; Seaways will file Form CB with the SEC for information documents
• · Receipt of consideration may be taxable for U.S. federal income tax purposes

16-10-2026

Brand Engagement Network Inc. (Nasdaq: BNAI, BNAIW) entered into a Settlement and Forbearance Agreement on September 30, 2026 with Evora Partners, LLC, resolving a roughly $1.3 million accounts payable obligation under a January 2021 consulting agreement for $825,000 (including a $75,000 attorneys' fee reimbursement). Evora will dismiss its September 2, 2026 breach of contract and declaratory relief lawsuit in the U.S. District Court for the Southern District of New York. The Company has paid $175,000 and will pay the remaining $650,000 in installments through December 2026, with guarantor BEN Capital Fund I, LLC guaranteeing payment.

• · Settlement represents a discount of roughly $475,000 (about 37%) from the ~$1.3M obligation carried in accounts payable
• · Lawsuit filed September 2, 2026 in S.D.N.Y. (Evora Partners, LLC v. Brand Engagement Network Inc.) asserted breach of contract and declaratory relief claims
• · Full Settlement Agreement expected to be filed as an exhibit to the Form 10-Q for the quarter ended September 30, 2026
• · Filing dated October 16, 2026 for an event on September 30, 2026; signed October 15, 2026
• · Company is an emerging growth company; warrants exercisable at $115.00 per share

16-10-2026

REGENXBIO Inc. (RGNX) disclosed that director Kenneth T. Mills resigned from its Board of Directors effective October 21, 2026, to focus on his new role as CEO of another company, stating the departure was not related to any disagreement with the Company. The Board appointed George Migausky as Chairman, and Daniel Tassé stepped down as Lead Independent Director under the Corporate Governance Guidelines but remains on the Board.

• · Mills' resignation is effective October 21, 2026, and was announced October 14, 2026
• · The new Chairman is an independent director, which is the stated reason Tassé stepped down as Lead Independent Director under the Corporate Governance Guidelines

16-10-2026

Truist Financial announced executive leadership appointments to strengthen its leadership depth as it focuses on growing core deposits, deepening primary banking relationships, and investing in client capabilities. D. Steve Boland joins as vice chair, Shimna Sameer becomes chief consumer banking officer, and Jeff Warner joins as chief small business banking officer, all reporting to CEO Mike Lyons. Dontá Wilson, chief consumer and small business banking officer, is leaving the bank.

• · Boland retired from Bank of America in 2025, where he was chief administrative officer and previously president of Retail Banking
• · Jeff Dunn and Bryan Cram will act as interim co-heads of Truist Wealth, reporting to Kristin Lesher
• · Warner most recently served as head of small business at PNC
• · Sameer was previously announced to lead Truist Wealth before this role change
• · Boland, Sameer and Warner will each report directly to CEO Mike Lyons

16-10-2026

Emergent BioSolutions announced that CFO Richard S. Lindahl will retire effective December 31, 2026, with Frank Vargo, VP and Treasurer, becoming interim CFO effective January 1, 2027. Lindahl will serve as a senior executive advisor from January 1 through March 31, 2027 to support the transition. The announcement is framed as part of the company's ongoing multi-year transformation plan, and the filing contains no quantitative performance data.

• · Frank Vargo has been with Emergent since 2019 and is serving as interim CFO, not a permanent appointment
• · Lindahl joined Emergent in 2018 after prior CFO roles at CEB and treasurer roles at Sprint Nextel
• · Lindahl will remain on the board of Compass Therapeutics, Inc. and pursue board service and advisory work after retirement
• · Filing states no permanent CFO search timeline; the interim arrangement's duration is not specified

16-10-2026

Remora Capital Corporation, an emerging growth company, entered into an amended and restated investment sub-advisory agreement on October 15, 2026 with Crescent Capital Group LP and Remora Capital Management, LLC. The amendment limits Crescent's advisory responsibilities to the Sub-Advised Assets and restricts Crescent from consulting other sub-advisers except as permitted under Rule 12d3-1 and Rule 17a-10 of the 1940 Act. No change was made to the management fee or the agreement term, which runs two years from September 5, 2025 and then renews annually subject to board approval.

• · The original Initial Sub-Advisory Agreement is dated September 5, 2025, and the amended agreement's two-year term runs from that date
• · The board, including a majority of non-interested directors, approved the amendment under the 1940 Act
• · The amended agreement is filed as Exhibit 10.1 to the 8-K

16-10-2026

AIBOTICS, INC. (AIBT) entered into an Asset Sale and Purchase Agreement on October 12, 2026 with PlayJamaica Limited to acquire robotics, drone, mapping, AI and NovaCore Labs-branded assets, closing on October 14, 2026 for 22,500 shares of Series B Preferred Stock (stated value $225,000) plus an earn-out of up to $3,000,000. Concurrently, the company granted employment packages to Gregory Moore and Ryan Moore, each including 50,000,000 common shares vesting over three years, performance cash bonuses, and Series B milestone awards, with the company committing up to $1,000,000 of capital to the subsidiary funded by a planned Regulation A offering. The filing carries significant dilution and funding-dependency risk, and the deal's scale is small relative to the share grants.

• · Combined up to 100,000,000 common shares to the two Moore employees, which is a material dilution event relative to typical micro-cap share counts; the filing does not disclose outstanding shares to quantify the percentage.
• · Earn-out to PlayJamaica is payable in four $750,000 tranches at cumulative revenue thresholds of $500K, $1.5M, $3M and $5M.
• · Either party may terminate the Purchase Agreement if closing has not occurred by December 31, 2026, although the filing states closing occurred October 14, 2026.
• · PlayJamaica may repurchase the assets if the company fails to fund the Subsidiary under the $1M budget and does not cure within 30 days of notice, repaying advances over 12 months at 8% interest under a secured note.
• · Indemnification liability is capped at the purchase price, and representations survive two years, except title, authority and IP ownership which survive indefinitely.
• · Gregory Moore's and Ryan Moore's employment agreements differ in bonus rate (10% vs 8% of NovaCore net income), governing law (Gregory's terms not specified; Ryan's governed by Florida law subject to Jamaican mandatory law) and severance for resignation without Good Reason (Ryan receives one month of benefits).

16-10-2026

26North BDC, Inc. and its affiliates entered into Amendment No. 5 (dated October 9, 2026) to the Loan and Security Agreement dated October 18, 2023, governing the 26N DL Funding 1 LLC secured credit facility with a JPMorgan Chase-led lender group. The amendment modifies portfolio, advance, and collection terms, is effective upon satisfaction of conditions including fee payment, officer certificates, opinions of counsel, and the absence of any Market Value Event, Default, or Event of Default. The filing does not disclose specific changes to financing commitment amounts, interest rates, or pricing within the exhibit excerpt provided.

• · Amendment No. 5 is dated October 9, 2026, and amends an agreement originally dated October 18, 2023, following prior amendments on July 3, 2024, September 30, 2024, November 15, 2024, and February 7, 2025
• · JPMorgan Chase Bank, National Association serves as Administrative Agent and Sole Lead Arranger; U.S. Bank Trust Company, National Association serves as Collateral Agent and Collateral Administrator
• · Effectiveness is conditioned on payment of Administrative Agent Fee, Arranger Fee, and other fees under the Administrative Agent Fee Letter, which are non-refundable once paid
• · The amendment is governed by New York law and may be executed in counterparts with electronic signatures accepted
• · The 26N Parties represented that no Default or Event of Default exists before or after giving effect to the amendment

16-10-2026

Jefferies Credit Partners BDC Inc. entered into Amendment No. 3 to its Credit Agreement dated as of October 9, 2026, with CIBC Bank USA as administrative agent. The amendment extends the Stated Termination Date to October 8, 2027, sets the Revolving Commitment at $100,000,000, and releases exiting lender Dime Community Bank upon payment of its Payoff Amount, with the other Lenders' commitments unchanged. The filing does not disclose any negative or flat performance metrics; it is a facility amendment and lender reallocation.

• · Third Amendment Effective Date is October 9, 2026; Stated Termination Date extended to October 8, 2027, subject to Section 6.5 extension
• · Existing Credit Agreement dated October 15, 2024, previously amended March 21, 2025 (Amendment No. 1) and October 10, 2025 (Amendment No. 2)
• · Dime Community Bank (Exiting Lender) is released from its Lender commitment upon receipt of the Payoff Amount, with Liens in its favor released
• · Other Lenders' Commitments are not reduced or terminated; outstanding Loans are reallocated pro rata to Commitments, which may trigger breakage amounts under Section 8.4 if repayment occurs off the last day of a Term SOFR Interest Period
• · Facility extension fee payable to the Administrative Agent (per Agent Fee Letters) and to Dime Bank as Lender (per Lender Fee Letter), plus Attorney Costs
• · Governed by New York law; board resolutions dated October 11, 2024 remain in effect

16-10-2026

Fox Factory announced that CEO Mike Dennison is stepping down, with independent director Douglas Grimm appointed Interim CEO effective October 16, 2026, and a search for a permanent CEO launched via Heidrick & Struggles. The company also issued preliminary Q3 FY2026 results below expectations: net sales of $336M to $340M versus guidance of $355M to $380M, and adjusted EBITDA of $38M to $42M (excluding about $12M of IEEPA tariff refunds) versus guidance of $46M to $54M. FY2026 guidance was cut to net sales of $1.35B to $1.38B (from $1.42B to $1.47B) and adjusted EBITDA of $140M to $150M excluding tariff refunds (from $176M to $196M), with the Marucci Sports divestiture closed September 25, 2026 and supply disruption, input-cost inflation, and upfit operating challenges cited as drivers.

• · Q3 FY2026 Marucci Sports net sales (~$33M) fell short of the ~$46M assumed in guidance, and Marucci underperformed before its September 25, 2026 closing
• · Q3 underperformance was attributed to Marucci Sports, a Powered Vehicles Group supply disruption with higher operating costs and unfavorable mix, upfit challenges in Aftermarket Applications, and softer bike sales in Specialty Sports
• · Q4 FY2026 adjusted EBITDA outlook cites higher aluminum, steel and freight inflation and lower chassis availability, with segment margins for Powered Vehicles and Aftermarket Applications expected roughly flat year over year
• · Company states the majority of expected IEEPA tariff refunds has been received and the outlook assumes no additional refunds; the Board seeks a permanent CEO with Heidrick & Struggles, and Grimm is not a candidate
• · Complete Q3 results, including GAAP reconciliation, will be filed in the Form 10-Q and earnings call is scheduled for November 5, 2026; preliminary figures are unaudited and subject to change

16-10-2026

FiEE, Inc. (Nasdaq: FIEE) disclosed that on October 12, 2026, director Angel Colon entered into an indemnification agreement with the Company in connection with his board appointment. On October 15, 2026, the Company's other directors and executive officers (Cao Yu, Chan Oi Fat, Hu Bin, Hongya Wen and Li Wai Chung) entered into the same form of indemnification agreement, superseding their existing agreements. The filing is a governance housekeeping disclosure with no financial terms, amounts, or performance data disclosed.

• · Indemnification agreements require the Company to indemnify covered directors and officers against certain liabilities arising from their service and to advance certain expenses
• · The form of Indemnification Agreement is filed as Exhibit 10.1 to the 8-K
• · Common stock trades under symbol FIEE on The Nasdaq Capital Market; company is headquartered in Osaka, Japan

16-10-2026

Maze Therapeutics, Inc. entered into an October 15, 2026 exchange agreement with four Frazier Life Sciences funds, exchanging 2,776,007 shares of common stock held by the funds for pre-funded warrants exercisable into the same number of shares at $0.001 per share. Following the exchange, Maze reports 53,931,889 common shares outstanding as of October 16, 2026. The transaction is a structural swap of existing shares into warrants rather than a new capital raise, so it does not bring in cash.

• · The Exchange Warrants were issued without registration under the Securities Act in reliance on Section 3(a)(9), an exemption for exchanges of securities with existing holders.
• · Exchange Warrants carry no voting rights except as required by Delaware law.
• · The exchange agreement and form of Exchange Warrant are filed as Exhibits 10.1 and 4.1.

16-10-2026

AT&T Inc. disclosed that Lori M. Lee, Global Marketing Officer & Senior Executive Vice President – International, will retire effective December 31, 2026, and her role will be eliminated following the company's agreement to sell its wireless business in Mexico and other reorganizational efforts. The filing contains no financial results, so no quantitative performance comparisons are reported, and the disclosure is primarily a leadership change tied to a divestiture.

• · Lori M. Lee's retirement is effective December 31, 2026, and the announcement was made October 14, 2026.
• · The Mexico wireless divestiture agreement was announced October 13, 2026, one day before the officer announcement.
• · The filing includes Item 9.01 with only a Cover Page Interactive Data File (Exhibit 104); no financial statements are attached.

16-10-2026

Copart's board granted CEO A. Jayson Adair a stand-alone nonstatutory stock option to purchase 20,000,000 shares, outside the 2007 Equity Incentive Plan and conditioned on stockholder approval at the 2026 Annual Meeting; if approval is not obtained, the option is forfeited. The option has four equal 5,000,000-share tranches at exercise prices of $26.27, $35.03, $43.78 and $52.54, a 10-year term, and vests on the 5th anniversary of the October 14, 2026 grant date, subject to continued service. Adair is expected to receive a $1 annual salary with no bonus or other equity awards during the 10-year period, other than approved perquisites.

• · Option granted outside the 2007 Equity Incentive Plan and forfeited entirely if stockholders do not approve at the 2026 Annual Meeting or a subsequent special meeting
• · Option vests only on the 5th anniversary of the grant date (October 14, 2031), subject to continued CEO service, with accelerated vesting on death or disability (based on 30-day average price exceeding exercise price) or on a change in control
• · Vested shares, and gains net of taxes on exercise, are subject to a service-based clawback of 10% per whole or partial year after CEO termination and a holding period through the 10-year term
• · Option is intended as the CEO's only substantive cash or equity compensation for 10 years, excluding approved perquisites
• · Option is subject to the Compensation Recovery Policy filed with the FY2026 10-K (fiscal year ended July 31, 2026)
• · Filing includes Exhibit 10.1 (the Option Agreement) and Inline XBRL cover page data

16-10-2026

WidePoint Corporation (NYSE American: WYY) disclosed that Chief Financial Officer Robert George tendered his resignation on October 9, 2026, effective upon filing of the Company's Form 10-Q for the quarter ended September 30, 2026. The resignation is attributed to personal and family reasons and is stated not to involve any disagreement with the Company. Mr. George will remain with the Company in a non-officer capacity to support an orderly transition.

• · Resignation effective upon filing of the Form 10-Q for the quarter ended September 30, 2026
• · Mr. George will continue assisting the Company in a non-officer capacity during the transition period
• · Filing states the resignation did not result from any disagreement with the Company

16-10-2026

TOMI Environmental Solutions appointed Niroshan Srirathan, 39, its Interim Chief Financial Officer since May 16, 2026, as permanent CFO effective October 11, 2026. He previously served as the Company's Controller from May 4, 2026, and has UK public-company finance experience at Vistry Group plc and Berkeley Group Holdings plc. The filing discloses an annual base salary of $205,000 under an offer letter, with no material related-party transactions or family relationships reported.

• · Srirathan served as Senior Finance Manager (Regional Comptroller) at Vistry Group plc from April 2024 to January 2025 and as Finance Transformation Lead at Berkeley Group Holdings plc from May 2020 to February 2024
• · He qualified as a Chartered Accountant in 2012 and is pursuing U.S. CPA qualification in Maryland
• · The full offer letter will be filed as an exhibit to the Company's next periodic report rather than with this 8-K

16-10-2026

Asure Software, Inc. entered into a Credit Agreement dated October 15, 2026 with MUFG Bank, Ltd. as Administrative Agent, Swingline Lender, L/C Issuer, and Sole Lead Arranger and Sole Bookrunner, providing up to $115,000,000 in loans and financial accommodations across Term A, Revolving, and DD Term facilities. The excerpt provided is the table of contents and the opening definitions of the agreement, so the pricing, maturity, covenant terms, and draw amounts by facility are not visible in this text.

• · Credit Agreement is dated October 15, 2026; the 8-K was filed October 16, 2026, with the agreement filed as Exhibit 10.1
• · Borrower is Asure Software, Inc., a Delaware corporation, with certain subsidiaries acting as Guarantors
• · Facilities include a Term A Facility, a Revolving Facility, and a DD Term Facility, with a Swingline sub-facility and letter of credit capacity
• · Items 1.01 (material agreement), 1.02 (termination of a material agreement, likely the refinancing of existing debt), 2.03 (creation of a direct financial obligation), 3.02 (unregistered sales of equity), 8.01 and 9.01 are reported in the filing
• · The agreement includes an Aggregate Adjustment Cap of 30% of Consolidated EBITDA on specified add-backs, and extensive covenants covering liens, indebtedness, investments, restricted payments, and financial covenants (Section 7.11)
• · Items 1.02 and 3.02 imply a prior credit facility was terminated and that equity was issued in an unregistered transaction, but these details are not included in the excerpt provided

16-10-2026

AMAZE HOLDINGS, INC. (AMZE) filed a Certificate of Designation creating a single share of Series X Preferred Stock, signed October 9, 2026 by CEO Joel Krutz. The Series X holder can vote only on proposals to increase authorized common stock to up to 4,000,000,000 shares and to effect reverse stock splits between 1-for-2 and 1-for-500 (combined maximum 1-for-500), with 51% of total voting power. The share carries no economic rights (no dividends, liquidation preference, conversion, or preemptive rights) and is automatically cancelled for no consideration one year after the filing.

• · The Series X holder has no economic entitlement: no dividends, no liquidation participation, and no conversion into common stock.
• · The designation is a governance/control mechanism tied to a potential increase in authorized common stock and reverse stock splits, implying possible future share capital actions.
• · The Series X share is automatically cancelled for no consideration on the one-year anniversary of filing with the Nevada Secretary of State, so its voting rights expire unless the holder is otherwise addressed.
• · Filing items 1.01, 3.02, 3.03, 5.03 and 9.01 indicate a material agreement, unregistered equity sale, modification of holder rights, and amendment to articles/bylaws; the exhibit provided does not include the underlying agreement or issuance terms, so the counterparty to the single share and any consideration paid are not disclosed in the excerpt.

16-10-2026

Ocular Therapeutix, Inc. (OCUL) disclosed that Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer, notified the Company on October 14, 2026 of his resignation, effective October 16, 2026, to become Chief Executive Officer of a privately-held company. The filing discloses no financial metrics, and it does not state a reason for the departure beyond the new role or name a successor.

• · Resignation notice dated October 14, 2026; effective date October 16, 2026
• · Departing officer is taking the CEO role at a privately-held company (name not disclosed)
• · No successor or interim Chief Strategy Officer is named in the filing

16-10-2026

Alliance Entertainment Holding Corp disclosed in an 8-K that its Compensation Committee authorized an increase in CFO Amanda Gnecco's annual base salary from $247,200 to $350,000, effective October 1, 2026. Her prorated target bonus for the fiscal year ending June 30, 2027 is set at $81,075. The filing reports a compensation change for an existing officer rather than a departure or new appointment.

• · The salary increase was authorized by the Compensation Committee of the Board of Directors on October 12, 2026
• · The bonus proration reflects a mid-year salary adjustment, with three months at the old salary rate and nine months at the new rate
• · Item 9.01 lists only the XBRL cover page interactive data file (Exhibit 104) with no other financial statements attached

16-10-2026

Bank of Marin Bancorp disclosed under Item 5.02 that Brandi Campbell, Executive Vice President and Head of Retail Banking at Bank of Marin, will leave the company effective October 16, 2026, by mutual agreement. Under a separation and release agreement, she is entitled to three months' pay as a lump sum (less applicable deductions) and nine months of COBRA premium reimbursement in exchange for a release of claims.

• · Separation is mutually agreed; no reason for departure is stated in the filing
• · Release of claims is required in exchange for severance, to the fullest extent permitted by law
• · Departing officer oversees the Head of Retail Banking function, a key customer-facing business line

16-10-2026

CalciMedica, Inc. (CALC) disclosed that Chief Financial Officer Stephen Bardin, who also serves as principal accounting officer and principal financial officer, resigned on October 15, 2026, to pursue another professional opportunity. The resignation takes effect immediately after the filing of the Company's Form 10-Q for the quarter ended September 30, 2026, and the company states it was not due to any disagreement with the Company.

• · Resignation notice provided October 15, 2026; effective immediately following filing of the Q3 2026 Form 10-Q (quarter ended September 30, 2026)
• · The 8-K states the resignation was not due to any disagreement with the Company
• · The CFO role also covers principal accounting officer duties, so the transition affects both financial and accounting leadership until a successor is named
• · The filing does not name a successor or interim CFO, and does not disclose any compensatory arrangements

16-10-2026

TScan Therapeutics, Inc. (Nasdaq: TCRX) disclosed that directors Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board and all committees effective October 13, 2026, with the company stating no disagreement over operations, practices, or policies. The Board filled the resulting Nominating and Corporate Governance Committee seats by appointing Stephen Biggar (member) and R. Keith Woods (chairperson), and reconstituted the Audit Committee to Katina Dorton, Barbara Klencke and R. Keith Woods.

• · Board resignations were effective the same day as the event (October 13, 2026) and the filing was made October 16, 2026
• · Resignations were explicitly not tied to any disagreement with the company
• · Stephen Biggar joins the Board's governance committee as a member; R. Keith Woods takes over as its chair

16-10-2026

Post Holdings disclosed that Senior Vice President and Chief Accounting Officer Bradly A. Harper is taking a temporary medical leave of absence, with CFO Matthew J. Mainer serving as Interim Chief Accounting Officer and principal accounting officer during the leave. The Board also approved an updated Code of Conduct on October 15, 2026, effective February 1, 2027, which modernizes the prior code without any waiver of its provisions. No financial metrics were disclosed in this filing.

• · The New Code covers emerging risk areas including artificial intelligence, prediction markets and fraud prevention
• · Expanded or restructured content addresses human rights, trade compliance, cybersecurity and data protection, workplace civility, records management, conflicts of interest and internal investigations
• · The Prior Code and New Code are posted on the company website under the Governance section of the Sustainability portion

16-10-2026

Waterstone Financial, Inc. (NASDAQ: WSBF) announced that director Derek L. Tyus has resigned from the Boards of the Company and WaterStone Bank, effective October 20, 2026, citing a new professional commitment and stating the resignation did not result from any disagreement with the company. Tyus had served since 2021 on the Company Board's Audit and Compensation Committees and the Bank Board's Executive Committee. The departure is governance-related and does not disclose any change in financial performance.

• · Tyus served on the Audit and Compensation Committees of the Company Board and the Executive Committee of the Bank Board
• · Resignation explicitly stated to be unrelated to any disagreement on operations, policies, or practices
• · Waterstone Mortgage Corporation is a wholly owned national lender licensed in 48 states

16-10-2026

Live Nation closed a $730.0M 7.125% senior notes offering due 2032 and a €600.0M 6.125% senior notes offering due 2032, with proceeds earmarked to redeem its 6.500% Senior Secured Notes due 2027. Cross-currency swaps bring the blended cost of the new notes to roughly 5.89%, versus 6.500% on the notes being retired. The company also amended its senior secured credit agreement, extending maturities one year to October 21, 2031 and increasing revolving and delayed-draw term loan commitments.

• · Notes mature October 15, 2032 with semi-annual coupons on April 15 and October 15 beginning April 15, 2027
• · Notes are senior unsecured and structurally subordinated to secured debt and non-guarantor subsidiaries
• · Indenture covenants restrict additional debt, restricted payments, asset sales, liens, mergers, and affiliate transactions, with many falling away under investment grade rating
• · Notes were sold under Rule 144A and Regulation S and are unregistered
• · Credit agreement maturity extended one year to October 21, 2031

16-10-2026

Laser Photonics Corp (NASDAQ: LASE) announced that founder Dmitri Nikitin has been appointed Executive Chairman and principal executive officer, assuming responsibilities previously held by CEO Wayne Tupuola, who resigned for medical reasons effective October 13, 2026. The company does not intend to appoint a separate CEO, and interim President Ann Tewari returned to her prior role as Global Vice President, Operations and Strategy. The filing contains no quantitative financial results, so no period-over-period comparison is available.

• · Nikitin's stated priorities include advancing the LSAD platform, strengthening engineering, building a disciplined marketing and sales organization, and integrating prior acquisitions and product lines
• · Company is pursuing defense applications (anti-drone directed energy) and modernizing domestic manufacturing capacity for U.S. military
• · Tupuola resigned due to medical reasons, a leadership transition with no separate CEO planned, concentrating executive authority in a single founder-led role

16-10-2026

Costco's Compensation Committee approved fiscal 2027 executive bonus criteria on October 13, 2026, with the Nominating and Governance Committee approving environmental and social performance criteria. Non-CEO executive officers are eligible for base bonuses of $400,000 (split $160,000 sales, $160,000 pre-tax income, and up to $80,000 for environmental and social objectives), while the CEO's base bonus is $1.2 million (split $500,000 sales, $500,000 pre-tax income, and up to $200,000 for environmental and social metrics). The filing discloses no officer departure or appointment, so the preliminary 'Officer Change' classification appears inaccurate.

• · Bonus structure allows payouts from zero up to 120% of target for each sales and pre-tax income goal
• · Environmental and social criteria include human capital and environmental-related quantitative metrics
• · The full Fiscal 2027 Executive Bonus Plan is filed as Exhibit 10.1
• · No director or officer departure, election, or appointment is reported in this filing

16-10-2026

NioCorp Developments Ltd. (NIOBW) disclosed that its majority-owned subsidiary Elk Creek Resources Corp. entered into a new 15-year Offtake Agreement with Traxys North America LLC on October 13, 2026, covering ferroniobium and other Elk Creek Critical Minerals Project products (scandium, titanium, rare earths). The agreement supersedes the prior ferroniobium and scandium offtake agreements with Traxys, which are terminated under Item 1.02. Traxys takes 50% of annual ferroniobium output on a take-or-pay basis (or, at its election, 3,700 metric tonnes per year) and holds exclusive marketing rights over all other products.

• · Traxys' exclusive worldwide sales rights for ferroniobium exclude the European Union while the existing Thyssen Krupp offtake agreement remains in effect
• · Ferroniobium pricing references a published monthly market price less a discount that steps up at five-year intervals over the term
• · Other Products are priced off published prices or, absent one, Traxys' arm's-length gross invoiced price, less a marketing commission and certain logistics, marketing and financing costs
• · Either party may terminate if EXIM has not granted final approval of senior debt financing or financial close has not occurred by December 31, 2027
• · Transfers of scandium oxide to ECRC affiliates for downstream conversion are not treated as sales, but third-party downstream scandium sales must be marketed through Traxys for a one-time commission
• · Item 1.02 covers termination of the Prior Ferroniobium Offtake Agreement, which was originally entered June 13, 2016, and assigned to Traxys

16-10-2026

Silver Bow Mining Corp. amended the vesting milestones on 200,000 performance warrants held by CEO C. Travis Naugle, replacing a preliminary economic assessment (PEA) milestone with milestones tied to its acquisition of the Jefferson County Metallurgical Complex and a term sheet with Ocean Partners UK Limited for approximately $88M in funding and offtake arrangements. The Board also approved a new grant of 2,000,000 performance warrants to Naugle, vesting on resource, market capitalization, and production milestones, both subject to NYSE American and shareholder approval. The filing is mixed for shareholders: it reflects a stronger acquisition and funding pipeline, but it adds material dilution tied to a CEO compensation package whose milestones have yet to be met.

• · The 200,000 warrants tied to the original PEA milestone are now tied to the Jefferson County acquisition closing and the Ocean Partners term sheet, which the Board deemed achieved as of October 2, 2026, pending NYSE American approval.
• · Shares underlying the New Performance Warrants may not be issued before shareholder approval; the Grant Date is set by that approval.
• · Exercise prices for New Performance Warrants reset upward to the current market price on the Grant Date if that price exceeds $12.00 (tranches i-iv) or $18.00 (production tranche), so holders receive no discount if the stock has risen.
• · Vesting on the two market capitalization tranches requires 30 consecutive trading days at or above $500M and $1B, respectively, before the fifth anniversary of the Grant Date.
• · The production tranche requires underground ore from the Rainbow Block to be processed and delivered at specified rates, with no single stoppage exceeding 10 consecutive days.
• · Warrants were issued under Section 4(a)(2) of the Securities Act, as disclosed under Item 3.02, a private placement exemption.
• · The Company is an emerging growth company, and its common shares trade on NYSE American under the symbol SBMT.

16-10-2026

PharmaCyte Biotech dismissed CBIZ CPAs P.C. as its independent registered public accounting firm on October 14, 2026, and engaged Grassi & Co., CPAs, P.C. to audit the fiscal year ending April 30, 2027 and review interim statements starting with the quarter ending October 31, 2026. CBIZ's prior audit reports on fiscal 2026 and 2025 contained no adverse opinion, disclaimer, or qualification, and no disagreements were reported. However, the filing discloses material weaknesses in internal control over financial reporting for both fiscal years, relating to insufficient segregation of duties of the Chief Financial Officer and insufficient management review controls.

• · The Audit Committee approved the Grassi engagement on the same day as the CBIZ dismissal, October 14, 2026.
• · CBIZ CPAs has been authorized to respond fully to Grassi's inquiries concerning the material weaknesses.
• · CBIZ's response letter (Exhibit 16.1), dated October 16, 2026, is filed with the SEC and will indicate whether CBIZ agrees with the company's Item 304 statements.
• · Grassi was not consulted on any accounting principle application, audit opinion type, disagreement, or reportable event in the two fiscal years or the interim period.

16-10-2026

High Roller Technologies (ROLR) disclosed under Item 4.02 that its unaudited financial statements for the quarters ended March 31, 2026 and June 30, 2026 should no longer be relied upon, due to an error in accounting for warrants issued to the placement agent in its January 2026 registered direct offering. Correcting the error reduces the net loss by approximately $1.0 million for both the three months ended March 31, 2026 (from $3.0 million to $2.0 million) and the six months ended June 30, 2026 (from $5.3 million to $4.3 million), while revenue, cash, working capital, stockholders' equity and cash flows are unaffected. The company also identified an additional material weakness in internal control over financial reporting and will file amended 10-Qs on October 16, 2026.

• · Company identified an additional material weakness in internal control over financial reporting as of March 31, 2026 and June 30, 2026, tied to its management review control over significant and unusual transactions
• · Restatement does not affect the three months ended June 30, 2026 results, as the error arose in Q1 2026
• · Compensation Committee concluded the restatement will not trigger clawback recovery of compensation
• · Amended Form 10-Q filings for both quarters are planned for October 16, 2026
• · Overstatement also applied to APIC and accumulated deficit by $1.0M each as of both balance sheet dates
• · Audit Committee discussed the matters with the independent registered public accounting firm, WithumSmith+Brown, PC

16-10-2026

Averin Capital Acquisition Corp. (ACAA), a Cayman Islands blank-check company, disclosed that director Mary Szela resigned effective October 16, 2026 from the Board, its Audit Committee, and as chairperson and member of the Compensation Committee, stating the resignation was not due to any disagreement with the Company. The Board filled the vacancies by appointing Graeme Bell as Compensation Committee chairperson and Akiko Moni Miyashita to the Audit Committee, both effective the same day. The filing contains no financial results, deal terms, or other quantitative disclosures.

• · Filing is an 8-K under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers)
• · Company is an emerging growth company listed on Nasdaq under tickers ACAAU, ACAA, and ACAAW
• · Preliminary classification of 'Merger/Acquisition' is not supported by the filing content, which discusses only board and committee changes

16-10-2026

Feel The World, Inc. (d/b/a XERO Shoes) disclosed that Chief Financial Officer Heidi Huntington resigned effective October 16, 2026, to pursue other professional opportunities, with no disagreement with the company cited. The board appointed Zachary Guzy as CFO effective upon her resignation, at an annual base salary of $290,000 plus eligibility for the annual bonus and equity compensation plans.

• · Huntington's resignation notice was given September 21, 2026, roughly three weeks before its October 16, 2026 effective date
• · Guzy previously served as CFO of Enthusiast Auto Holdings, a private-equity-backed e-commerce company, and as CFO and COO of mDesign Global
• · The filing states Huntington's departure was not the result of any disagreement with the company on operations, policies, or practices

16-10-2026

SentinelOne announced a proposed private placement of $1.25 billion of 0.00% Convertible Senior Notes due 2031, with an option for initial purchasers to buy up to an additional $187.5 million. Proceeds are earmarked for capped call transactions, a repurchase of up to $150.0 million of Class A common stock concurrent with pricing, and general corporate purposes including potential acquisitions. The company also intends to enter a $400 million secured revolving credit facility, but no credit agreement has been executed and the offering is not contingent on it.

• · Notes are unsecured general senior obligations; settlement on conversion may be cash, Class A shares, or a combination at company election
• · Share repurchases priced at closing price on pricing date and may raise the effective conversion price of the notes
• · Option counterparties' hedging and unwinding activity could move the Class A stock price and affect conversion value
• · Notes and underlying shares are unregistered under the Securities Act and cannot be offered in the U.S. absent registration or exemption
• · Completion of the offering is not contingent on entering the credit agreement, which lenders' terms may not make favorable

16-10-2026

DataMeds AI, Inc. (Nasdaq: MEDS) entered into an Intellectual Property License and Product and Services Agreement with REBOOT Health AI, Inc. on October 13, 2026, granting an exclusive U.S. license within a GLP-1 direct-to-consumer field of use in exchange for 666,667 restricted common shares (valued at $2,000,000) plus a $50,000 payment toward a platform reconfiguration estimated at a minimum of $100,000. The company also disclosed that it is working to regain compliance with the Nasdaq $2,500,000 minimum stockholders' equity requirement, which it believes it now exceeds following equity issuances and debt settlements, though Nasdaq has not yet confirmed compliance and delisting remains possible at the next periodic report if compliance is not evidenced.

• · Company licenses REBOOT patents and platform exclusively in the U.S. for GLP-1 user management, limited to B2C model; no B2B sales to healthcare providers except limited exceptions
• · Company receives no source code and may not modify, reverse engineer, or create derivative works; REBOOT retains ownership of all platform reconfigurations and enhancements
• · Revenue Sharing Agreement gives REBOOT a portion of Adjusted Gross Revenue from the company's use of the technology, after certain cost deductions
• · Shortfall mechanism: if shares are worth less than $2,000,000 at 180 days, the company must issue additional shares based on the 10-day VWAP
• · Agreement runs until expiration or invalidity of the last licensed patent, subject to minimum revenue thresholds
• · Nasdaq deficiency letter received April 13, 2026; company has not yet received Nasdaq's formal confirmation of compliance
• · Full IP License Agreement to be filed as an exhibit to the Form 10-Q for the quarter ended September 30, 2026